The third transmembrane domains of the human B1 and B2 bradykinin receptor subtypes are involved in discriminating between subtype-selective ligands

被引：0
|
作者：
Fathy, DB [1 ]
Mathis, SA [1 ]
Leeb, T [1 ]
Leeb-Lundberg, LMF [1 ]
机构：
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
来源：
FASEB JOURNAL | 1997年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
2751
引用
收藏
页码：A1328 / A1328
页数：1
相关论文
共 50 条
  • [21] Ca2+ signaling of kinins in cells expressing rat, mouse and human bradykinin B1/B2 receptor
    Zubakova, R.
    Gille, A.
    Faussner, A.
    Hilgenfeldt, U.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 48 - 48
  • [22] Two B1 and B2 bradykinin receptor antagonists fail to inhibit the Ca2+ response elicited by bradykinin in human skin fibroblasts
    Cassano, G
    Susca, F
    Lippe, C
    Guanti, G
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1999, 32 (02): : 239 - 244
  • [23] Expression of the bradykinin B1 and B2 receptors in human airway epithelial cells.
    Eddleston, J
    Fox, AJ
    Lim, S
    Donnelly, LE
    Newton, R
    Haddad, EB
    Chung, KF
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A180 - A180
  • [24] Development of subtype-selective covalent ligands for the adenosine A2B receptor by tuning the reactive group
    Beerkens, Bert L. H.
    Wang, Xuesong
    Avgeropoulou, Maria
    Adistia, Lisa N.
    van Veldhoven, Jacobus P. D.
    Jespers, Willem
    Liu, Rongfang
    Heitman, Laura H.
    IJzerman, Adriaan P.
    van der Es, Daan
    RSC MEDICINAL CHEMISTRY, 2022, 13 (07): : 850 - 856
  • [25] Spontaneous formation of a proteolytic B1 and B2 bradykinin receptor complex with enhanced signaling capacity
    Kang, DS
    Ryberg, K
    Mörgelin, M
    Leeb-Lundberg, LMF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) : 22102 - 22107
  • [26] Bradykinin B2, but not B1, receptor antagonism has a neuroprotective effect after brain injury
    Görlach, C
    Hortobágyi, T
    Hortobágyi, S
    Benyó, Z
    Relton, J
    Whalley, ET
    Wahl, M
    JOURNAL OF NEUROTRAUMA, 2001, 18 (08) : 833 - 838
  • [27] Variation in the bradykinin receptor B1 and B2 genes alters the cardiovascular risk associated with hypertension
    Dhamrait, SS
    Payne, JR
    Li, P
    Jones, A
    Toor, IS
    Cooper, JA
    Hawe, E
    Palmen, J
    Wootton, P
    Miller, G
    Humphries, SE
    Montgomery, HE
    HEART, 2003, 89 : A30 - A30
  • [28] Neuroprotection by a bradykinin B2 receptor antagonist after traumatic brain injury is not attenuated by the simultaneous application of a bradykinin B1 receptor antagonist
    Görlach, C
    Hortobágyi, T
    Hortobágyi, S
    Benyó, Z
    Relton, JK
    Whalley, ET
    Wahl, M
    JOURNAL OF PHYSIOLOGY-LONDON, 2000, 526 : 50P - 51P
  • [29] Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from brain oedema, postischaemic inflammation and cerebral infarction
    Austinat, M. L.
    Braeuninger, S.
    Stoll, G.
    Renne, T.
    Kleinschnitz, C.
    JOURNAL OF NEUROLOGY, 2008, 255 : 49 - 49
  • [30] IDENTIFICATION OF DOMAINS OF THE HUMAN A(1) ADENOSINE RECEPTOR THAT ARE IMPORTANT FOR BINDING-RECEPTOR SUBTYPE-SELECTIVE LIGANDS USING CHIMERIC A(1)/A(2A) ADENOSINE RECEPTORS
    RIVKEES, SA
    LASBURY, ME
    BARBHAIYA, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (35) : 20485 - 20490
12345